Global Medicaments Containing Insulin Market 2023

Medicaments Containing Insulin Market Size

The global medicaments containing insulin market dropped modestly to $X in 2021, waning by -3.5% against the previous year. Overall, consumption, however, recorded a deep setback. Over the period under review, the global market attained the peak level at $X in 2012; however, from 2013 to 2021, consumption failed to regain momentum.

Medicaments Containing Insulin Production

In value terms, medicaments containing insulin production rose markedly to $X in 2021 estimated in export price. Overall, production, however, recorded a pronounced decline. The growth pace was the most rapid in 2016 when the production volume increased by 8.8% against the previous year. Over the period under review, global production hit record highs at $X in 2012; however, from 2013 to 2021, production remained at a lower figure.

Medicaments Containing Insulin Exports

Exports

In 2021, shipments abroad of medicaments containing insulin but not antibiotics decreased by -39.7% to X tons for the first time since 2017, thus ending a three-year rising trend. In general, exports, however, continue to indicate a resilient increase. The growth pace was the most rapid in 2019 with an increase of 84% against the previous year. Over the period under review, the global exports hit record highs at X tons in 2020, and then fell markedly in the following year.

In value terms, medicaments containing insulin exports dropped sharply to $X in 2021. Overall, exports showed a abrupt slump. The pace of growth was the most pronounced in 2016 when exports increased by 31% against the previous year. The global exports peaked at $X in 2012; however, from 2013 to 2021, the exports failed to regain momentum.

Exports by Country

The United States prevails in exports structure, recording X tons, which was near 92% of total exports in 2021. Thailand (X tons) held a minor share of total exports.

Exports from the United States increased at an average annual rate of +13.1% from 2012 to 2021. At the same time, Thailand (+102.4%) displayed positive paces of growth. Moreover, Thailand emerged as the fastest-growing exporter exported in the world, with a CAGR of +102.4% from 2012-2021. The United States (+39 p.p.) and Thailand (+2.7 p.p.) significantly strengthened its position in terms of the global exports, while the shares of the other countries remained relatively stable throughout the analyzed period.

In value terms, the United States ($X) remains the largest medicaments containing insulin supplier worldwide, comprising 84% of global exports. The second position in the ranking was taken by Thailand ($X), with a 0.6% share of global exports.

From 2012 to 2021, the average annual rate of growth in terms of value in the United States totaled -6.6%.

Export Prices by Country

The average medicaments containing insulin export price stood at $X per ton in 2021, rising by 4.4% against the previous year. Overall, the export price, however, faced a abrupt contraction. The pace of growth was the most pronounced in 2016 an increase of 40%. Over the period under review, the average export prices hit record highs at $X per ton in 2012; however, from 2013 to 2021, the export prices failed to regain momentum.

There were significant differences in the average prices amongst the major exporting countries. In 2021, amid the top suppliers, the country with the highest price was the United States ($X per ton), while Thailand stood at $X per ton.

From 2012 to 2021, the most notable rate of growth in terms of prices was attained by the United States (-17.4%).

Medicaments Containing Insulin Imports

Imports

In 2021, approx. X tons of medicaments containing insulin but not antibiotics were imported worldwide; which is down by -51.8% against the previous year. Over the period under review, imports faced a abrupt slump. The most prominent rate of growth was recorded in 2020 with an increase of 202% against the previous year. Global imports peaked at X tons in 2012; however, from 2013 to 2021, imports failed to regain momentum.

In value terms, medicaments containing insulin imports contracted sharply to $X in 2021. Overall, imports continue to indicate a abrupt descent. The most prominent rate of growth was recorded in 2016 when imports increased by 87% against the previous year. Over the period under review, global imports attained the maximum at $X in 2012; however, from 2013 to 2021, imports stood at a somewhat lower figure.

Imports by Country

Denmark dominates imports structure, finishing at X tons, which was near 67% of total imports in 2021. Brazil (X tons) took a 6.8% share (based on physical terms) of total imports, which put it in second place, followed by Malaysia (4.8%). The following importers - Nigeria (X tons), Kuwait (X tons), Ethiopia (X tons) and Japan (X tons) - together made up 9.6% of total imports.

Imports into Denmark increased at an average annual rate of +27.5% from 2012 to 2021. At the same time, Brazil (+42.6%), Japan (+32.4%), Ethiopia (+17.3%), Kuwait (+8.8%) and Malaysia (+2.0%) displayed positive paces of growth. Moreover, Brazil emerged as the fastest-growing importer imported in the world, with a CAGR of +42.6% from 2012-2021. By contrast, Nigeria (-2.5%) illustrated a downward trend over the same period. While the share of Denmark (+67 p.p.), Brazil (+6.7 p.p.), Malaysia (+3.8 p.p.), Kuwait (+2.5 p.p.), Nigeria (+2 p.p.), Ethiopia (+2 p.p.) and Japan (+1.6 p.p.) increased significantly, the shares of the other countries remained relatively stable throughout the analyzed period.

In value terms, Denmark ($X) constitutes the largest market for imported medicaments containing insulin but not antibiotics worldwide, comprising 66% of global imports. The second position in the ranking was taken by Brazil ($X), with a 6.3% share of global imports. It was followed by Nigeria, with a 4.4% share.

From 2012 to 2021, the average annual rate of growth in terms of value in Denmark totaled +20.7%. In the other countries, the average annual rates were as follows: Brazil (+37.4% per year) and Nigeria (+10.8% per year).

Import Prices by Country

The average medicaments containing insulin import price stood at $X per ton in 2021, with an increase of 73% against the previous year. In general, the import price recorded a noticeable increase. The pace of growth was the most pronounced in 2016 an increase of 103%. Global import price peaked at $X per ton in 2018; however, from 2019 to 2021, import prices remained at a lower figure.

There were significant differences in the average prices amongst the major importing countries. In 2021, amid the top importers, the country with the highest price was Japan ($X per ton), while Malaysia ($X per ton) was amongst the lowest.

From 2012 to 2021, the most notable rate of growth in terms of prices was attained by Japan (+22.1%), while the other global leaders experienced more modest paces of growth.

Source: IndexBox Market Intelligence Platform

Frequently Asked Questions (FAQ) :